Applications of 3D Tumor Models in Cancer Drug Discovery
.png)
On-Demand WebinarCancer claims over 10 millions deaths annually worldwide, underscoring the urgent need for better therapies. Currently, fewer than 5% of oncology drug candidates succeed in reaching the market, largely due to limitations in preclinical models that fail to replicate the complexity of human tumors and their microenvironment.Join Karla Queiroz, PhD ( Senior Scientist at MIMETAS) as she showcases how complex 3D in vitro models are redefining cancer research and drug discovery with human-relevant insights for the study of small molecules, antibodies and CAR T-cell therapies.Webinar Highlights- Explore our comprehensive 3D human tumor models that incorporate patient-derived materials, ECM components, endothelial networks, and complex co-cultures with stromal and immune cells, enabling immune infiltration and predictive drug testing studies.- Learn how our automated microfluidic OrganoPlate® platform supports robust drug screening with reproducible, scalable results.- Discover how to quantify tumor behavior, immune response, and vascularization through high-content imaging and validated assays.
Applications of 3D Tumor Models in Cancer Drug Discovery
Applications of 3D Tumor Models in Cancer Drug Discovery
Join Karla Queiroz, PhD ( Senior Scientist at MIMETAS) as she showcases how complex 3D in vitro models are redefining cancer research and drug discovery with human-relevant insights for the study of small molecules, antibodies and CAR T-cell therapies.
Applications of 3D Tumor Models in Cancer Drug Discovery
Join Karla Queiroz, PhD ( Senior Scientist at MIMETAS) as she showcases how complex 3D in vitro models are redefining cancer research and drug discovery with human-relevant insights for the study of small molecules, antibodies and CAR T-cell therapies.
Applications of 3D Tumor Models in Cancer Drug Discovery
Join Karla Queiroz, PhD ( Senior Scientist at MIMETAS) as she showcases how complex 3D in vitro models are redefining cancer research and drug discovery with human-relevant insights for the study of small molecules, antibodies and CAR T-cell therapies.
Applications of 3D Tumor Models in Cancer Drug Discovery
Join Karla Queiroz, PhD ( Senior Scientist at MIMETAS) as she showcases how complex 3D in vitro models are redefining cancer research and drug discovery with human-relevant insights for the study of small molecules, antibodies and CAR T-cell therapies.
Applications of 3D Tumor Models in Cancer Drug Discovery
Join Karla Queiroz, PhD ( Senior Scientist at MIMETAS) as she showcases how complex 3D in vitro models are redefining cancer research and drug discovery with human-relevant insights for the study of small molecules, antibodies and CAR T-cell therapies.
Applications of 3D Tumor Models in Cancer Drug Discovery
Join Karla Queiroz, PhD ( Senior Scientist at MIMETAS) as she showcases how complex 3D in vitro models are redefining cancer research and drug discovery with human-relevant insights for the study of small molecules, antibodies and CAR T-cell therapies.
Applications of 3D Tumor Models in Cancer Drug Discovery
Join Karla Queiroz, PhD ( Senior Scientist at MIMETAS) as she showcases how complex 3D in vitro models are redefining cancer research and drug discovery with human-relevant insights for the study of small molecules, antibodies and CAR T-cell therapies.
Applications of 3D Tumor Models in Cancer Drug Discovery
Join Karla Queiroz, PhD ( Senior Scientist at MIMETAS) as she showcases how complex 3D in vitro models are redefining cancer research and drug discovery with human-relevant insights for the study of small molecules, antibodies and CAR T-cell therapies.